RIVERSIDE UNIVERSITY HEALTH SYSTEM — History
CCN 050292 | 3-year financial timeline | COVID resilience: 72/100
🛡️ Public data only — no PHI permitted on this instance.
$917M
Latest Revenue (FY2022)
+24.1%
Revenue CAGR (3yr)
-10.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $596M | $805M | $917M | +14.0% | +24.1% |
| Operating Expenses | $679M | $794M | $1.0B | +27.5% | +22.0% |
| Operating Margin | -13.9% | 1.4% | -10.3% | -840.9% | +0.0% |
| Net Income | $-83M | $11M | $-94M | -944.7% | +0.0% |
| Licensed Beds | 423 | 423 | 423 | +0.0% | +0.0% |
| Total Patient Days | 116,842 | 130,450 | 141,074 | +8.1% | +9.9% |
| Medicare Day % | 12% | 10% | 11% | +11.5% | -0.6% |
| Medicaid Day % | 15% | 15% | 13% | -14.9% | -7.9% |
COVID Impact & Recovery
Resilience Score: 72/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +53.9% ($596M → $917M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+24.1%
This Hospital
+7.6%
State Avg
Latest Margin
-10.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $1.1B | -8.4% |
| FY2024 (proj) | $1.2B | -6.6% |
| FY2025 (proj) | $1.4B | -4.8% |